NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-146-2018-0-CN-04 CAR T-cells Targeting CAIX For Glioblastoma Therapy CN National Stage 2019800462586 Pending
NCI E-139-2018-0-CA-05 WATER SOLUBLE NOVEL CYANINE FLUOROPHORE WITH TUNABLE PROPERTIES BETWEEN NEAR IR AND SWIR REGION FOR IN VIVO IMAGING CA National Stage 3106249 Pending
CC E-183-2016-0-US-04 DETECTION OF PROSTATE CANCER IN MULTI-PARAMETRIC MRI USING RANDOM FOREST WITH INSTANCE WEIGHTING & MR PROSTATE SEGMENTATION BY DEEP LEARNING WITH HOLISTICALLY-NESTED NETWORKS US National Stage 16/488,127 11200667 Issued PDF
NEI E-077-2018-0-PCT-02 METHODS OF METABOLIC REGULATION OF MITOCHONDRIA FOR TREATING NEURAL INJURY AND NEUROLOGICAL DISORDERS PCT PCT PCT/US2019/047504 Expired
NCI E-254-2005-2-US-26 Optimization Of Expression Of Human Interleukin-15 (IL-15) And Improved DNA Vector Combinations Of IL-15 And IL-15 Receptor Alpha And Protein Combinations Of Same That Increase Cytokine Stability And Biological Function In Vivo And In Vitro US DIV 16/547,039 Pending
NEI E-077-2018-0-CN-03 METHODS OF METABOLIC REGULATION OF MITOCHONDRIA FOR TREATING NEURAL INJURY AND NEUROLOGICAL DISORDERS CN National Stage 201980061762.3 Pending
CC E-183-2016-0-JP-09 DETECTION OF PROSTATE CANCER IN MULTI-PARAMETRIC MRI USING
RANDOM FOREST WITH INSTANCE WEIGHTING & MR PROSTATE
SEGMENTATION BY DEEP LEARNING WITH HOLISTICALLY-NESTED NETWORKS 		JP National Stage 2019-545291 Issued
NHLBI E-342-2013-0-US-06 Human IPSC-derived Vascular-related And Hematopoetic Cells For Therapies And Toxicology/drug Screenings US DIV 16/544,381 11072778 Issued PDF
NIDDK E-132-2018-1-PCT-01 PURINE AND PYRIMIDINE NUCLEOTIDES AS ECTO-5’-NUCLEOTIDASE INHIBITORS PCT PCT PCT/US2019/046931 Expired
NCI E-298-2016-0-US-04 EFFICIENT CELL FREE PRODUCTION OF PAPILLOMAVIRUS GENE TRANSFER VECTORS US National Stage 16/486,626 Abandoned
NLM E-107-2010-2-US-27 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 16/541,857 10774373 Issued PDF
NCI E-063-2017-0-AU-03 DENOISING OF DYNAMIC MAGNETIC RESONANCE SPECTROSCOPIC
IMAGING USING LOW RANK APPROXIMATIONS IN THE KINETIC DOMAIN 		AU National Stage 2018221015 Issued
NCI E-063-2017-0-US-07 Denoising Of Dynamic Magnetic Resonance Spectroscopic Imaging Using Low Rank Approximations In The Kinetic Domain US National Stage 16/485,772 Pending
NIDCR E-175-2015-1-EP-06 AAV Isolate and Fusion Protein Comprising Nerve Growth Factor Signal Peptide and Parathyroid Hormone EP DIV 19191545.3 Abandoned
NCI E-230-2012-0-MX-16 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 MX DIV MX/a/2019/009641 Pending
NIAID E-038-2017-1-US-03 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US National Stage 16/485,354 11021535 Issued PDF
NCI E-230-2012-0-AU-15 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 AU DIV 2019213329 Issued
NCI E-198-2018-0-PCT-02 High Affinity Monoclonal Antibodies Targeting Glypican-2 For Treating Childhood Cancers PCT PCT PCT/US2019/045338 Expired
NCI E-198-2018-0-CN-05 High Affinity Monoclonal Antibodies Targeting Glypican-2 For Treating Childhood Cancers CN National Stage 201980053942.7 Pending
NCI E-198-2018-0-EP-06 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF EP National Stage 19759784.2 Pending
NCI E-198-2018-0-CA-04 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF CA National Stage 3106544 Pending
NCI E-084-2016-0-US-18 Methods Of Preparing T Cells For T Cell Therapy US CON 16/533,109 Pending
NCI E-198-2018-0-AU-03 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF AU National Stage 2019317565 Pending
NIAID E-050-2018-0-PCT-02 Nipah Virus Immunogens And Their Use PCT PCT PCT/US2019/045110 Expired
NIAID E-050-2018-0-CN-04 Nipah Virus Immunogens And Their Use CN National Stage 201980051936.8 Pending
NIAID E-050-2018-0-EP-05 Nipah Virus Immunogens And Their Use EP National Stage 19755481.9 Pending
NIAID E-050-2018-0-IN-06 Nipah Virus Immunogens And Their Use IN National Stage 202117006653 Pending
NIAID E-050-2018-0-AU-03 Nipah Virus Immunogens And Their Use AU National Stage 2019315602 Pending
NCATS E-026-2016-0-CL-15 Compounds for Improving MRNA Splicing CL DIV 2019-02167 Pending
NCI E-035-2021-0-PCT-02 TREATMENT AND DIAGNOSIS OF BREAST CANCER PCT PCT PCT/HU2019/050038 Expired
NCI E-086-2015-0-EP-05 Bispecific Multivalent Fusion Proteins EP DIV 19189394.0 Pending
NICHD E-039-2015-0-US-09 ADENO-ASSOCIATED VIRUS VECTORS ENCODING MODIFIED G6PC AND USES THEREOF US DIV 16/526,327 11535870 Issued PDF
NCI E-267-2016-0-US-06 Synthetic Self-assembling Peptide Antagonists Of Human CCR3 For The Treatment Of Inflammatory Diseases US CON 16/525,056 Pending
NICHD E-072-2017-0-US-07 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE US National Stage 16/481,430 Abandoned
NCATS E-046-2018-2-US-02 AUTOPHAGY INDUCERS FOR TREATMENT OF CNS CONDITIONS US National Stage 16/480,885 11241436 Issued PDF
NIAID E-099-2016-0-US-19 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 16/522,357 10980846 Issued PDF
NIAID E-099-2016-0-US-18 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 16/522,333 10946049 Issued PDF
NIAID E-099-2016-1-US-05 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 16/522,379 10653727 Issued PDF
NCI E-181-2018-2-PCT-01 OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (Top1) AND TYROSYL-DNA PHOSPHODIESTERASE 1(Tdp1) PCT PCT COMB PCT/US2019/043357 Expired
NCI E-181-2018-2-EP-03 OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (Top1) AND TYROSYL-DNA PHOSPHODIESTERASE 1(Tdp1) EP National Stage 19750204.0 Pending
NCI E-181-2018-2-CN-02 OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (Top1) AND TYROSYL-DNA PHOSPHODIESTERASE 1(Tdp1) CN National Stage 2019800629175 Pending
NCI E-086-2012-2-US-10 Methods for Generation of Pluripotent and Multipotent Cells US CON 16/521,251 11692175 Issued PDF
NIAID E-145-2015-3-US-05 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV US CON 16/521,327 10576059 Issued PDF
NIAID E-004-2009-2-US-17 Virus Like Particle Compositions and Methods of Use US DIV 16/520,113 11369674 Issued PDF
NICHD E-247-2009-2-IL-10 Dendrimer Based Nanodevices For Therapeutic And Imaging Purposes IL DIV 268181 Issued
NCI E-495-2013-0-CN-18 ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS CN DIV 201910649441.7 Issued
NHLBI E-134-2017-3-US-02 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 US National Stage 16/479,183 11136372 Issued PDF
NCI E-266-2011-0-IL-36 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage IL DIV 268157 Issued
NEI E-164-2018-3-PCT-01 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS PCT PCT COMB PCT/US2019/042365 Expired
NINDS E-088-2018-1-US-12 HERV-K Antibody For Treatment Of ALS US National Stage 16/478,576 10723787 Issued PDF